全球基因组学市场预测（2025-2030）

全球基因组学市场预计将从 2025 年的 359 亿美元成长到 2030 年的 623.97 亿美元，复合年增长率为 11.69%。

全球基因组学市场正经历强劲成长，这得益于疾病（尤其是癌症）发病率的上升，以及政府和私营部门推动基因研究的倡议不断增加。基因组学涵盖重组DNA、DNA定序和生物资讯学，能够分析生物体的整个基因组，并支持基因治疗、个人化医疗和临床研究的应用。市场对创新治疗解决方案的需求以及行业参与者之间的合作推动了该市场的蓬勃发展。

市场驱动因素

疾病发生率上升和癌症基因组学

疾病（尤其是遗传性癌症）的日益普及是基因组学市场的主要驱动力。对人类基因组的深入了解正在推动利用 CRISPR-Cas 等技术治疗癌症的先进基因疗法的发展。癌症基因组学因其在识别基因突变、开发标靶治疗以及改善治疗效果和患者预后方面的潜力而日益增长。

政府和私部门的倡议

政府和私营部门的大量投资正在加速基因组学研究。例如，英国研发部于2022年12月拨款1.75亿英镑用于基因组学研究，以支持一项为期三年的计划，旨在开发和部署尖端基因组医学技术。这些旨在透过分析患者DNA来改善诊断和治疗的倡议正在推动市场成长。同样，製药和生技公司也在大力投资药物研发和个人化医疗，并透过创新的研发策略进一步推动市场发展。

共同努力和行业伙伴关係

产业联盟、合资企业和收购正在推动基因组学市场的成长。这些伙伴关係促进了尖端技术的整合，并扩展了基因组学在诊断和精准医疗领域的应用范围。高度重视合作研究可以促进创新，从而开发新的工具和平台来应对复杂的健康挑战。

地理视角

北美洲

由于大型製药公司和研究机构的集中，北美在全球基因组学市场占据重要份额。该地区强大的基础设施支持着人类基因组计划和癌症基因组图谱计划等倡议，这些计划推动了基因组学在疾病研究和治疗开发中的应用。美国仍然保持领先地位，并因其对基因表现及其对健康结果的影响而推动市场扩张。

亚太地区

受疾病盛行率上升和对创新疗法和诊断需求不断增长的推动，亚太地区预计将实现高复合年增长率。政府和私营部门的倡议，例如大规模人类基因序列测定计划，正在推动市场成长。该地区被定位为重要的成长中心，尤其是在中国和印度等致力于透过基因组学应对健康挑战的国家。

市场趋势

基因组学市场的特点是采用最尖端科技，例如用于基因编辑的 CRISPR-Cas 以及整合生物资讯学进行全面的基因组分析。个人化医疗和癌症基因组学日益增长的需求正在推动诊断和治疗应用的创新。收购和合资企业等合作发展正在加强先进基因组平台的开发。此外，政府和私营部门对精准医疗和药物研发的投入不断增加，也与全球卫生优先事项一致。

受疾病（尤其是癌症）发病率上升以及政府和私营倡议的大力推动，基因组学市场预计将显着增长。北美凭藉强大的製药和研究生态系统处于领先地位，而亚太地区则由于诊断和治疗需求的不断增长而迅速扩张。先进的基因编辑、合作伙伴关係和创新工具的趋势正在塑造市场的未来。随着对个人化医疗和基因组医疗保健的日益关注，基因组学市场在预测期内应对关键健康挑战的同时，已准备好实现持续扩张。

本报告的主要优点

• 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分领域。
• 竞争格局：了解主要企业正在采取的策略倡议，并了解正确策略的市场渗透潜力。
• 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
• 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
• 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具成本效益的。

报告的主要用途

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

调查范围

• 2022-2024年实际数据及2025-2030年预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 各地区（包括细分市场和国家）的收益成长和预测分析
• 公司简介（主要包括策略、产品、财务资讯、主要发展动态等）

目录

第一章 引言

• 市场概况
• 市场定义
• 调查范围
• 市场区隔
• 货币
• 先决条件
• 基准年和预测年时间表

第二章调查方法

• 调查数据
• 资讯来源
• 研究设计

第三章执行摘要

• 调查重点

第四章 市场动态

• 市场驱动因素
• 市场限制
• 波特五力分析
• 产业价值链分析

第五章全球基因体学市场的应用

• 介绍
• 药物发现与开发
• 诊断
• 精准医疗
• 农业和动物研究
• 其他用途

6. 全球基因体学市场（依最终用户划分）

• 介绍
• 医院和诊所
• 研究中心和政府机构
• 製药和生物技术公司
• 其他的

7. 全球基因体学市场（按技术）

• 介绍
• PCR
• 定序
• 微阵列
• 核酸萃取与纯化
• 其他的

8. 全球基因体学市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 以色列
  • 其他的
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 印尼
  • 台湾
  • 其他的

第九章：竞争格局及分析

• 主要企业和策略分析
• 新兴企业和市场盈利
• 併购、协议和合作
• 供应商竞争力矩阵

第十章：公司简介

• Illumina, Inc
• Thermo Fisher Scientific, Inc
• Qiagen
• Bio-Rad Laboratories, Inc
• Danaher
• BGI Genomics
• F. Hoffmann-La Roche
• Merck KGaA
• Integrated DNA Technologies, Inc.
• Agilent Technologies, Inc.

The genomics market is expected to grow from USD 35.900 billion in 2025 to USD 62.397 billion in 2030, at a CAGR of 11.69%.

The global genomics market is experiencing robust growth, driven by the rising prevalence of diseases, particularly cancer, and increasing government and private initiatives to advance genetic research. Genomics, encompassing recombinant DNA, DNA sequencing, and bioinformatics, analyzes an organism's entire genome, supporting applications in gene therapy, personalized medicine, and clinical research. The market is propelled by the demand for innovative therapeutic solutions and collaborative efforts among industry players.

Market Drivers

Rising Disease Prevalence and Cancer Genomics

The increasing incidence of diseases, particularly inherited cancers, is a primary driver of the genomics market. The growing understanding of the human genome has spurred the development of advanced gene therapies, leveraging technologies like CRISPR-Cas for cancer treatment. The demand for cancer genomics is rising due to its potential to identify genetic variations and develop targeted therapies, enhancing treatment efficacy and patient outcomes.

Government and Private Initiatives

Significant government and private sector investments are accelerating genomics research. For instance, in December 2022, the UK Department of Health and Social Care allocated £175 million to fund genomics research, supporting a three-year plan to develop and implement cutting-edge genomic healthcare technologies. These initiatives aim to analyze patients' DNA to improve diagnostics and treatment, driving market growth. Similarly, pharmaceutical and biotechnology companies are investing heavily in drug discovery and personalized medicine, further boosting the market through innovative research and development strategies.

Collaborative Efforts and Industry Partnerships

Collaborations, joint ventures, and acquisitions among industry players are enhancing genomics market growth. These partnerships facilitate the integration of advanced technologies and expand the scope of genomic applications in diagnostics and precision medicine. The focus on collaborative research is fostering innovation, enabling the development of novel tools and platforms to address complex health challenges.

Geographical Outlook

North America

North America holds a significant share of the global genomics market, driven by its concentration of major pharmaceutical companies and research organizations. The region's robust infrastructure supports initiatives like the Human Genome Project and the Cancer Genome Atlas Program, which advance genomic applications in disease research and therapeutic development. The U.S. remains a leader due to its focus on genetic expression and its impact on health outcomes, supporting market expansion.

Asia-Pacific

The Asia-Pacific region is expected to grow at a high compound annual growth rate (CAGR), fueled by the rising prevalence of diseases and increasing demand for innovative therapeutic drugs and diagnostics. Government and private sector initiatives, such as large-scale human genome sequencing projects, are driving market growth. The region's focus on addressing health challenges through genomics, particularly in countries like China and India, positions it as a key growth hub.

Market Trends

The genomics market is characterized by the adoption of cutting-edge technologies like CRISPR-Cas for gene editing and the integration of bioinformatics for comprehensive genome analysis. The rising demand for personalized medicine and cancer genomics is driving innovation in diagnostic and therapeutic applications. Collaborative efforts, such as acquisitions and joint ventures, are enhancing the development of advanced genomic platforms. The market also benefits from increased government funding and private sector investment in precision medicine and drug discovery, aligning with global health priorities.

The genomics market is poised for significant growth, driven by the rising prevalence of diseases, particularly cancer, and robust government and private initiatives. North America leads due to its strong pharmaceutical and research ecosystem, while Asia-Pacific is set for rapid expansion with increasing demand for diagnostics and therapeutics. Trends toward advanced gene editing, collaborative partnerships, and innovative tools are shaping the market's future. As the focus on personalized medicine and genomic healthcare intensifies, the genomics market is well-positioned for sustained expansion, addressing critical health challenges during the forecast period.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Technology

• PCR
• Sequencing
• Microarray
• Nucleic Acid Extraction and Purification
• Others

By Application

• Drug Discovery and Development
• Diagnostics
• Precision Medicine
• Agriculture and Animal Research
• Other Applications

By End-User

• Hospitals & Clinics
• Research Centers & Government Institutes
• Pharmaceutical & Biotechnology Companies
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East And Africa
• Saudi Arabia
• Israel
• Other
• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Sources
• 2.3. Research Design

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. GLOBAL GENOMICS MARKET BY APPLICATION

• 5.1. Introduction
• 5.2. Drug Discovery and Development
• 5.3. Diagnostics
• 5.4. Precision Medicine
• 5.5. Agriculture and Animal Research
• 5.6. Other Applications

6. GLOBAL GENOMICS MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals & clinics
• 6.3. Research centers & Government Institutes
• 6.4. Pharmaceutical & Biotechnology Companies
• 6.5. Others

7. GLOBAL GENOMICS MARKET BY TECHNOLOGY

• 7.1. Introduction
• 7.2. PCR
• 7.3. Sequencing
• 7.4. Microarray
• 7.5. Nucleic Acid Extraction and Purification
• 7.6. Others

8. GLOBAL GENOMICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East And Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. Israel
  • 8.5.3. Other
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. Japan
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Taiwan
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. Illumina, Inc
• 10.2. Thermo Fisher Scientific, Inc
• 10.3. Qiagen
• 10.4. Bio-Rad Laboratories, Inc
• 10.5. Danaher
• 10.6. BGI Genomics
• 10.7. F. Hoffmann-La Roche
• 10.8. Merck KGaA
• 10.9. Integrated DNA Technologies, Inc.
• 10.10. Agilent Technologies, Inc.